Thematic ETF Daily Trading Outlook

March 26, 2026

Theme Signal

The market remains trapped in the same macro box: oil up, yields up, equities down. Thematic leadership is narrowing toward biotech, selective semis, and speculative rebound pockets, while software, homebuilders, and energy-transition beta are again vulnerable to renewed macro stress.

Investment Digest

U.S. equities finished higher on Wednesday, but the rally was uneven and still heavily dependent on de-escalation hopes surrounding Iran. The Dow rose 0.66%, the S&P 500 gained 0.54%, the Nasdaq added 0.77%, and the Russell 2000 outperformed with a 1.23% gain. Under the surface, dispersion remained the key feature: China tech, airlines, industrial metals, banks, payments, and trucking led, while energy, homebuilders, exchanges, casual dining, and real estate lagged. Big tech was mixed, with Google and Meta underperforming, semis firmer, and memory and large-cap software softer.

Wednesday’s move was helped by a combination of lower oil, lower yields, and renewed diplomatic chatter. The market leaned on reports of a U.S. proposal for a one-month ceasefire, talk of Vice President Vance playing a role in negotiations, and the possibility of a higher-level meeting between the sides. It also benefited from cleaner positioning after earlier de-risking and from attention on month-end buying flows. But none of that removed the underlying skepticism: Iran continued to reject the U.S. offer publicly, the Strait of Hormuz remained central to the conflict, and U.S. troop deployment headlines kept the geopolitical backdrop fragile.

This morning, the tone has flipped back to risk-off. S&P futures are down 0.8%, Treasuries are back under pressure with yields up 6–7 bp across much of the curve, the dollar is slightly firmer, gold is down 2.7%, silver is down 6.3%, and WTI is up 3.7%. The market is again trading the familiar pattern of oil up, yields up, stocks down, with fresh attention on an Axios report that the U.S. is weighing military options for a “final blow.” The issue is no longer just whether a ceasefire is possible; it is how much structural damage has already been done and how much spillover into demand destruction, inflation expectations, and liquidity conditions still lies ahead.

Today’s main domestic focus is initial claims, with consensus near 210K, and another Treasury test comes with the $44B 7-year note auction after weak 2- and 5-year sales earlier this week. Markets also remain highly sensitive to the idea that the Fed’s reaction function has turned more hawkish in the face of energy-driven inflation pressure and constrained rate-cut expectations.

Thematic Tail of the Tape

For thematic investors, the 3/26 tape says the rebound is getting narrower and more speculative.

The clearest strength in the 3/26 theme file is biotech. The top performers are dominated by LABU, XBI, and SBIO, which suggests capital is rotating into higher-beta healthcare and idiosyncratic drug-development exposure rather than broad defensives. That fits Wednesday’s single-stock backdrop, where Sarepta surged on trial data and biotech also got support from the Merck–Terns transaction news. In other words, biotech is being treated less as a safe haven and more as a source of event-driven upside.

The second notable pocket is speculative tech and crypto-adjacent beta. WGMI and UFO rank among the strongest one-day performers, showing that even in a still-difficult macro backdrop, investors are selectively re-engaging with higher-volatility thematic expressions when sentiment improves. But that strength remains tactical rather than structural.

The more durable message still sits in the flow data. Over both 1-month and YTD horizons, investors continue to favor dividend equity, software, and broad equity quality, with strong inflows into EFG, VTI, IGV, SCHD, and CGDV/VYM-type exposures. That suggests the strategic preference remains the same: own themes with earnings visibility, balance-sheet resilience, and cleaner monetization pathways.

At the same time, the biggest outflow buckets remain gold, silver, semis at the margin, and broad internet beta. That is important. Even after Wednesday’s rally, investors are still using GLD, SLV, SMH, and FDN as funding sources or trimming points. Thematic investors appear increasingly unwilling to pay up for crowded macro hedges or richly owned growth beta unless the earnings case is unmistakable.

The split inside technology is also becoming sharper. Semiconductors remain more resilient than software, but even there investors are differentiating between AI enablers with clear demand visibility and memory or hardware names exposed to compression risk. Wednesday’s market recap made that explicit: semis outperformed, but memory weakened following Google’s TurboQuant update.

The takeaway is that thematic allocation still prefers quality growth and monetizable AI, but the risk budget is getting tighter. The market is willing to trade biotech, semis, and speculative rebounds tactically, yet the strategic flow pattern still points toward quality, dividends, and selective software rather than a broad re-risking.

Bottom Line

The 3/26 setup says the market is still willing to chase biotech and selective speculative rebounds, but the broader thematic allocation picture has not really changed. Quality dividend exposure and software still dominate the strategic inflow picture, while metals, broad internet beta, and macro-hedge trades like gold and silver remain under pressure on a net basis. Until oil and yields both turn decisively lower, thematic leadership is likely to stay narrow, tactical, and highly headline-sensitive.

Thematic ETF Performance — Top 5 (1D)

Thematic ETF Performance — Bottom 5 (1D)

ETF Fund Flows — Top 5 Inflows (1M)

ETF Fund Flows — Top 5 Outflows (1M)

ETF Fund Flows — Top 5 Inflows (YTD)

ETF Fund Flows — Top 5 Outflows (YTD)